{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["4"],"submitter":["Khedgikar V"],"pubmed_abstract":["Withania somnifera or Ashwagandha is a medicinal herb of Ayurveda. Though the extract and purified molecules, withanolides, from this plant have been shown to have different pharmacological activities, their effect on bone formation has not been studied. Here, we show that one of the withanolide, withaferin A (WFA) acts as a proteasomal inhibitor (PI) and binds to specific catalytic β subunit of the 20S proteasome. It exerts positive effect on osteoblast by increasing osteoblast proliferation and differentiation. WFA increased expression of osteoblast-specific transcription factor and mineralizing genes, promoted osteoblast survival and suppressed inflammatory cytokines. In osteoclast, WFA treatment decreased osteoclast number directly by decreasing expression of tartarate-resistant acid p"],"journal":["Cell death & disease"],"pagination":["e778"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3763455"],"repository":["biostudies-literature"],"pubmed_title":["Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone."],"pmcid":["PMC3763455"],"pubmed_authors":["Kushwaha P","Sharma S","Trivedi PK","Gautam J","Mishra PR","Singh D","Verma A","Sangwan NS","Trivedi R","Nagar GK","Changkija B","Kumar A","Khedgikar V"],"additional_accession":[]},"is_claimable":false,"name":"Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.","description":"Withania somnifera or Ashwagandha is a medicinal herb of Ayurveda. Though the extract and purified molecules, withanolides, from this plant have been shown to have different pharmacological activities, their effect on bone formation has not been studied. Here, we show that one of the withanolide, withaferin A (WFA) acts as a proteasomal inhibitor (PI) and binds to specific catalytic β subunit of the 20S proteasome. It exerts positive effect on osteoblast by increasing osteoblast proliferation and differentiation. WFA increased expression of osteoblast-specific transcription factor and mineralizing genes, promoted osteoblast survival and suppressed inflammatory cytokines. In osteoclast, WFA treatment decreased osteoclast number directly by decreasing expression of tartarate-resistant acid p","dates":{"release":"2013-01-01T00:00:00Z","publication":"2013 Aug","modification":"2025-04-04T09:40:24.243Z","creation":"2019-03-27T01:15:32Z"},"accession":"S-EPMC3763455","cross_references":{"pubmed":["23969857"],"doi":["10.1038/cddis.2013.294"]}}